Special Issue "Totally Intracorporeal Urinary Diversion after Robot-Assisted Radical Cystectomy for Muscle-Invasive Bladder Cancer"
Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 3711
Interests: muscle-invasive bladder cancer; prostate cancer; oligometastasis; robot-assisted surgery; intracorporeal urinary diversion; ileal neobladder; ileal conduit
Special Issues, Collections and Topics in MDPI journals
Radical cystectomy (RC) remains the gold standard of treatment for muscle-invasive bladder cancer (MIBC). Minimally invasive surgical techniques have been widely used in a variety of surgical procedures. Of all of them, robot-assisted RC (RARC) has technical advantages over laparoscopic RC and emerged as a better alternative to open RC due to its possible reduction in estimated blood loss, blood transfusion rate, and quicker recovery of bowel function.
Although robotic surgery has advanced, experience in total intracorporeal urinary diversion (ICUD), including intracorporeal ileal conduit or neobladder reconstruction, remains limited. Most surgeons have performed the hybrid approach of RARC and extracorporeal urinary diversion since ICUD remains technically challenging. Although ICUD may have several potential advantages, the adoption of ICNB has been limited to high-volume academic institutions.
This Special Issue aims to summarize the utility and safety of RARC followed by totally ICUD in patients with MIBC at the authors’ institutions, especially focusing on perioperative morbidities and oncological outcomes.
Dr. Takuya Koie
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- robot-assisted radical cystectomy
- intracorporeal urinary diversion
- muscle-invasive bladder cancer
- ileal conduit
- ileal neobladder